| USD millions | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 16.4 | 21.7 | 18.7 | 10.3 | 8.9 | −13.1% | |
| Selling, general & administrative | 3.8 | 3.3 | 6.5 | 12.2 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 20.2 | 25.0 | 25.2 | 22.5 | 20.8 | −7.7% | |
| Operating income | (20.2) | (25.0) | (25.2) | (22.5) | (20.8) | +7.7% | |
| Interest expense | 0.0 | 0.0 | (0.0) | 0.0 | 0.0 | +0.0% | |
| Interest income | 0.0 | 0.4 | 0.2 | 0.3 | 0.3 | +18.1% | |
| Other income / expense | 0.0 | 0.2 | (2.1) | 0.3 | — | — | |
| Pre-tax income | (20.2) | (24.7) | (27.3) | (22.2) | (20.5) | +8.0% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (20.2) | (24.7) | (27.3) | (22.2) | (20.5) | +8.0% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (1.34) | (1.65) | (3.26) | (1.06) | (0.89) | +16.4% | |
| EPS, diluted (per share) | (1.34) | (1.65) | (3.26) | (1.06) | (0.89) | +16.4% | |
| EBITDA | (20.1) | (24.4) | (25.2) | (22.2) | (20.7) | +6.8% | |
| Depreciation & amortization | 0.1 | 0.3 | 2.1 | 0.0 | — | — | |
| Weighted average shares (shares) | 15,033,731 | 15,033,731 | 19,514,684 | 21,021,817 | — | — | |
| Weighted average diluted shares (shares) | 15,033,731 | 15,033,731 | 19,514,684 | 21,021,817 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
